ELOQUINE 250mg tablets medication leaflet

P01BC02 mefloquine • Antiparasitic products, insecticides and repellents | Antimalarials | Methanolquinolines

Mefloquine is a medication used for the prevention and treatment of malaria. It is effective against several Plasmodium species, including Plasmodium falciparum, which is responsible for severe forms of malaria.

This medication is taken orally, usually once a week for prophylaxis or according to a specific regimen for treatment. It is important to start taking it at least one week before traveling to an endemic area and to continue for several weeks after returning.

Mefloquine may cause side effects such as nausea, dizziness, or sleep disturbances. In rare cases, neuropsychiatric reactions such as anxiety or depression may occur. Patients with a history of psychiatric disorders should avoid using this medication.

To ensure effectiveness, it is essential to follow the dosing schedule and consult a doctor before use, especially if taking other medications.

General data about ELOQUINE 250mg

Substance: mefloquine

Date of last drug list: 01-09-2022

Commercial code: W54015001

Concentration: 250mg

Pharmaceutical form: tablets

Quantity: 100

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: MEDOCHEMIE LTD. - CIPRU

Holder: CN UNIFARM S.A. - ROMANIA

Number: 515/2020/01

Shelf life: 60 months

Pharmaceutical forms available for mefloquine

Other substances similar to mefloquine